Fibrosis Unknown Status Phase 4 Trials for Spironolactone (DB00421)

Also known as: Fibrosis (morphologic abnormality) / Fibrosis (qualifier value) / Fibrosis NOS

IndicationStatusPhase
DBCOND0012375 (Fibrosis)Unknown Status4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02948998Evaluating the Effect of Spironolactone on Hypertrophic CardiomyopathyTreatment